Main menu

NCM 2023 Singapore: Direct detection of DNA modifications in human cancer genomes


Epigenomic aberration is one of the hallmarks of cancer genomes. Global hypomethylation, aberrant hypermethylation at transcriptional regulatory regions (e.g. promoters, enhancers) and loss of imprinting have been widely revealed by short-read sequencing and methylation microarrays, but it can be difficult to assess the detailed modification status on a long, continuous read. Here we evaluated the accuracy and feasibility of native DNA sequencing using PromethION from Oxford Nanopore Technologies to detect a long-ranged and haplotype-resolved methylation level in the cancer genome. In addition, we propose the importance of integrated analysis of cytosine modifications to consider the dynamics of 5-methylcytosine and its oxidation derivatives.

Authors: Genta Nagae

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

ナノポア技術

ナノポアの最新ニュースを購読 リソースと発表文献 Nanopore Communityとは

Oxford Nanoporeについて

ニュース 会社沿革 持続可能性 経営陣 メディアリソース & お問い合わせ先 投資家向け パートナー向け Oxford Nanopore社で働く 現在の募集状況 営業上の情報 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag